Alembic Pharmaceuticals Ltd
NSE:APLLTD
Alembic Pharmaceuticals Ltd
NSE:APLLTD
Price:
778
INR
-4%
Market Cap:
₹152.9B
Relative Value
The Relative Value of one
APLLTD
stock under the Base Case scenario is
hidden
INR.
Compared to the current market price of 778 INR,
Alembic Pharmaceuticals Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
APLLTD Relative Value
HIDDEN
Multiples Across Competitors
APLLTD Competitors Multiples
Alembic Pharmaceuticals Ltd Competitors
Alembic Pharmaceuticals Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Alembic Pharmaceuticals Ltd
NSE:APLLTD
|
153.2B INR | 2.2 | 24 | 14.7 | 19.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
964.4B USD | 16.2 | 52.4 | 35.2 | 37.7 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
572.6B USD | 6.1 | 21.4 | 14.9 | 18.2 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
284.4B CHF | 4.6 | 30.2 | 12.8 | 14.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
297.7B USD | 4.6 | 16.3 | 10.2 | 11.9 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
217.3B GBP | 5.2 | 31.9 | 15.2 | 22.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
227.3B CHF | 5.2 | 20.3 | 12.8 | 16.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK | 4 | 12.3 | 8.6 | 10 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
151.1B USD | 2.4 | 19.4 | 7.3 | 9.7 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120.9B USD | 2.5 | 20 | 7.1 | 9.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
